BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with ...

The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.68 in the third quarter of fiscal 2025, up 5.1% year over year. The figure topped the Zacks ...

Discover how Becton Dickinson (BDX) achieved 8.5% revenue growth, expanded margins, and raised guidance in Q3 2025.

As of 30 June 2025, total equity attributable to shareholders reached BD 43,141,313, a 1% decline from the BD 43,377,483 ...

BD will invest $35M to expand its Nebraska syringe plant, adding 50 jobs and boosting U.S. supply of essential medical ...

Connecticut College researchers have found that chemical byproducts produced by the amphibian-killing fungus Batrachochytrium ...

The good doctor and a former familiar face at the detective desk in the Special Victims Unit are set to return to the beloved ...